Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| 908 Devices Inc.MASS · Entity 5564 | Director | June 11, 2025 | June 13, 2025 |
| Amneal Pharmaceuticals, Inc.AMRX · Entity 820 | Director | May 06, 2026 | May 08, 2026 |
| LENZ Therapeutics, Inc.LENZ · Entity 6475 | Director | June 15, 2026 | June 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
908 Devices Inc.
Report date June 11, 2025 · Filed June 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,814 |
Reported balance
After 2025-06-11 transaction · row 1
1 source rowRow 1 · 2025-06-11 · Exercise / conversion · Acquired 11,364 · Balance 26,814 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-06-11 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-06-11 · Exercise / conversion · Disposed 11,364 · Balance 0 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. F2: The RSUs became fully vested on June 11, 2025, the day prior to the 2025 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 14,083 |
Reported balance
After 2025-06-12 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-06-12 · Grant · Acquired 14,083 · Balance 14,083 F3: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F4: The RSUs become fully vested on June 12, 2026 or the day prior to the 2026 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. |
| Stock Option (option to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.19 · Expires 2035-06-11 | Direct | 6,516 |
Reported balance
After 2025-06-12 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-06-12 · Grant · Acquired 6,516 · Balance 6,516 F5: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 12, 2025, subject to the reporting person's continued service through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date.
F2: The RSUs became fully vested on June 11, 2025, the day prior to the 2025 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date.
F3: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested.
F4: The RSUs become fully vested on June 12, 2026 or the day prior to the 2026 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date.
F5: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 12, 2025, subject to the reporting person's continued service through the applicable vesting date.
Amneal Pharmaceuticals, Inc.
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 344,614 |
Reported balance
After 2026-05-07 transaction · row 1
1 source rowRow 1 · 2026-05-07 · Exercise / conversion · Acquired 34,819 · Balance 344,614 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-07 · Exercise / conversion · Disposed 34,819 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2: On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 19,824 |
Reported balance
After 2026-05-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-06 · Grant · Acquired 19,824 · Balance 19,824 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2: On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026.
F3: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.
LENZ Therapeutics, Inc.
Report date June 15, 2026 · Filed June 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.63 · Expires 2036-06-15 | Direct | 22,100 |
Reported balance
After 2026-06-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-15 · Grant · Acquired 22,100 · Balance 22,100 F1: Subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's Outside Director Compensation Policy) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier to occur of June 15, 2027 or the date of the next annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's Outside Director Compensation Policy) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier to occur of June 15, 2027 or the date of the next annual meeting of stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2026 Filed Jun 16, 2026 00:18 UTC | LENZ Therapeutics, Inc. LENZ · Entity 6475 | GrantStock Option (right to buy) · Derivative | 22,100 | $0.00 Strike: $6.63 | $0.00 |
DisclosureSEC source: 0001796789-26-000004 · wk-form4_1781569101.xml · derivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,100 Underlying: Common Stock · 22,100 shares Expires 2036-06-15 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's Outside Director Compensation Policy) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier to occur of June 15, 2027 or the date of the next annual meeting of stockholders. Read SEC document |
| May 07, 2026 Filed May 8, 2026 20:27 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionRestricted Stock Units · Derivative | 34,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-032924 · wk-form4_1778272051.xml · derivative · entry 2 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 34,819 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026. F2 · derivative.expiration_date: On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026. Read SEC document |
| May 07, 2026 Filed May 8, 2026 20:27 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionClass A Common Stock | 34,819 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-032924 · wk-form4_1778272051.xml · nonDerivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 344,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 06, 2026 Filed May 8, 2026 20:27 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | GrantRestricted Stock Units · Derivative | 19,824 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-032924 · wk-form4_1778272051.xml · derivative · entry 3 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,824 Underlying: Class A Common Stock · 19,824 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. F3 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Read SEC document |
| March 27, 2026 Filed Mar 30, 2026 12:47 UTC | LENZ Therapeutics, Inc. LENZ · Entity 6475 | PurchaseCommon Stock | 5,592 | $8.92 | $49,890.15 |
DisclosureSEC source: 0001796789-26-000003 · wk-form4_1774874821.xml · nonDerivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,592 F1 · price: Represents the weighted average share price of an aggregate total of 5,592 shares purchased in the price range of $8.80 to $9.12 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 20:20 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantStock Option (option to buy) · Derivative | 6,516 | $0.00 Strike: $7.19 | $0.00 |
DisclosureSEC source: 0001562180-25-004808 · primarydocument.xml · derivative · entry 4 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,516 Underlying: Common Stock · 6,516 shares Expires 2035-06-11 F5 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 12, 2025, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 20:20 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantRestricted Stock Units · Derivative | 14,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004808 · primarydocument.xml · derivative · entry 3 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,083 Underlying: Common Stock · 14,083 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F4 · derivative.exercise_date: The RSUs become fully vested on June 12, 2026 or the day prior to the 2026 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F4 · derivative.expiration_date: The RSUs become fully vested on June 12, 2026 or the day prior to the 2026 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| June 11, 2025 Filed Jun 11, 2025 21:46 UTC | LENZ Therapeutics, Inc. LENZ · Entity 6475 | GrantStock Option (right to buy) · Derivative | 13,500 | $0.00 Strike: $30.00 | $0.00 |
DisclosureSEC source: 0001815776-25-000048 · wk-form4_1749678400.xml · derivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2035-06-10 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's Outside Director Compensation Policy) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on June 11, 2026. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 20:20 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionRestricted Stock Units · Derivative | 11,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004808 · primarydocument.xml · derivative · entry 2 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,364 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. F2 · derivative.exercise_date: The RSUs became fully vested on June 11, 2025, the day prior to the 2025 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs became fully vested on June 11, 2025, the day prior to the 2025 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 20:20 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionCommon Stock | 11,364 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-25-004808 · primarydocument.xml · nonDerivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. Read SEC document |
| May 06, 2025 Filed May 8, 2025 22:57 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | GrantRestricted Stock Units · Derivative | 34,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-023989 · wk-form4_1746745065.xml · derivative · entry 3 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,819 Underlying: Class A Common Stock · 34,819 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. F3 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Read SEC document |
| May 05, 2025 Filed May 8, 2025 22:57 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionRestricted Stock Units · Derivative | 40,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-023989 · wk-form4_1746745065.xml · derivative · entry 2 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 40,258 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025. F2 · derivative.expiration_date: On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025. Read SEC document |
| May 05, 2025 Filed May 8, 2025 22:57 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionClass A Common Stock | 40,258 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-023989 · wk-form4_1746745065.xml · nonDerivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 309,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 20:20 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantStock Option (option to buy) · Derivative | 15,996 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001562180-24-005062 · primarydocument.xml · derivative · entry 4 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,996 Underlying: Common Stock · 15,996 shares Expires 2033-06-15 F5 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 13, 2024, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 20:20 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantRestricted Stock Unit · Derivative | 11,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-005062 · primarydocument.xml · derivative · entry 3 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,364 Underlying: Common Stock · 11,364 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F4 · derivative.exercise_date: The RSUs become fully vested on June 13, 2025 or the day prior to the 2025 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F4 · derivative.expiration_date: The RSUs become fully vested on June 13, 2025 or the day prior to the 2025 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:20 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionRestricted Stock Unit · Derivative | 7,777 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-005062 · primarydocument.xml · derivative · entry 2 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,777 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. F2 · derivative.exercise_date: The RSUs became fully vested on June 12, 2024, the day prior to the 2024 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs became fully vested on June 12, 2024, the day prior to the 2024 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:20 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionCommon Stock | 7,777 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-005062 · primarydocument.xml · nonDerivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. Read SEC document |
| May 10, 2024 Filed May 14, 2024 20:42 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionRestricted Stock Units · Derivative | 76,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-023248 · wk-form4_1715719307.xml · derivative · entry 2 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 76,453 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: On May 9, 2023 the reporting person was granted 76,453 restricted stock units vesting on May 10, 2024. F2 · derivative.expiration_date: On May 9, 2023 the reporting person was granted 76,453 restricted stock units vesting on May 10, 2024. Read SEC document |
| May 10, 2024 Filed May 14, 2024 20:42 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionClass A Common Stock | 76,453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-023248 · wk-form4_1715719307.xml · nonDerivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 02, 2024 Filed May 6, 2024 21:28 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | GrantRestricted Stock Units · Derivative | 40,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-020730 · wk-form4_1715030871.xml · derivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,258 Underlying: Class A Common Stock · 40,258 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. F2 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Read SEC document |
| March 21, 2024 Filed Mar 26, 2024 00:38 UTC | LENZ Therapeutics, Inc. LENZ · Entity 6475 | GrantStock Option (right to buy) · Derivative | 27,000 | $0.00 Strike: $15.05 | $0.00 |
DisclosureSEC source: 0001815776-24-000025 · wk-form4_1711413477.xml · derivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 27,000 shares Expires 2034-03-20 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, one thirty-sixth (1/36th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 21, 2024. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 21:11 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionRestricted Stock Unit · Derivative | 508 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-001695 · primarydocument.xml · derivative · entry 2 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.001 · 508 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F2 · derivative.exercise_date: The RSUs become vested in substantially equal annual installments over the 3 years following February 22, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs become vested in substantially equal annual installments over the 3 years following February 22, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 21:11 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionCommon Stock, par value $0.001 | 508 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-001695 · primarydocument.xml · nonDerivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 21:51 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantStock Option (option to buy) · Derivative | 12,076 | $0.00 Strike: $8.68 | $0.00 |
DisclosureSEC source: 0001562180-23-005304 · primarydocument.xml · derivative · entry 4 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,076 Underlying: Common Stock · 12,076 shares Expires 2033-06-15 F5 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 15, 2023, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 21:51 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantRestricted Stock Units · Derivative | 7,777 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005304 · primarydocument.xml · derivative · entry 3 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,777 Underlying: Common Stock · 7,777 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F4 · derivative.exercise_date: The RSUs become fully vested on June 15, 2024 or the day prior to the 2024 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F4 · derivative.expiration_date: The RSUs become fully vested on June 15, 2024 or the day prior to the 2024 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:51 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionRestricted Stock Units · Derivative | 4,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005304 · primarydocument.xml · derivative · entry 2 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,771 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. F2 · derivative.exercise_date: The RSUs became fully vested on June 14, 2023, the day prior to the 2023 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs became fully vested on June 14, 2023, the day prior to the 2023 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:51 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionCommon Stock | 4,771 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-005304 · primarydocument.xml · nonDerivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,165 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. Read SEC document |
| May 10, 2023 Filed May 11, 2023 20:15 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionRestricted Stock Units · Derivative | 80,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028729 · doc4.xml · derivative · entry 3 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 80,128 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023. F3 · derivative.expiration_date: On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023. Read SEC document |
| May 10, 2023 Filed May 11, 2023 20:15 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionClass A Common Stock | 80,128 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-028729 · doc4.xml · nonDerivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:15 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | GrantRestricted Stock Units · Derivative | 76,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028729 · doc4.xml · derivative · entry 2 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,453 Underlying: Class A Common Stock · 76,453 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. F2 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 21:28 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionRestricted Stock Unit · Derivative | 507 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001756 · primarydocument.xml · derivative · entry 2 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 508 Underlying: Common Stock, par value $0.001 · 1,015 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F2 · derivative.exercise_date: The RSUs become vested in substantially equal annual installments over the 3 years following February 22, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs become vested in substantially equal annual installments over the 3 years following February 22, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 21:28 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionCommon Stock, par value $0.001 | 507 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-001756 · primarydocument.xml · nonDerivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 20:17 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantStock Option (option to buy) · Derivative | 7,970 | $0.00 Strike: $14.15 | $0.00 |
DisclosureSEC source: 0001562180-22-005195 · primarydocument.xml · derivative · entry 4 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,970 Underlying: Common Stock, par value $0.001 · 7,970 shares Expires 2032-06-16 F4 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 16, 2022, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 20:17 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantRestricted Stock Unit · Derivative | 4,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-005195 · primarydocument.xml · derivative · entry 3 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,771 Underlying: Common Stock, par value $0.001 · 4,771 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F3 · derivative.exercise_date: The RSUs become fully vested on June 16, 2023 or the day prior to the 2023 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F3 · derivative.expiration_date: The RSUs become fully vested on June 16, 2023 or the day prior to the 2023 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:17 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionRestricted Stock Unit · Derivative | 1,379 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-005195 · primarydocument.xml · derivative · entry 2 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.001 · 1,379 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F2 · derivative.exercise_date: The RSUs became fully vested on June 15, 2022, the day prior to the 2022 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs became fully vested on June 15, 2022, the day prior to the 2022 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:17 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionCommon Stock, par value $0.001 | 1,379 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-005195 · primarydocument.xml · nonDerivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. Read SEC document |
| May 09, 2022 Filed May 10, 2022 22:44 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | GrantRestricted Stock Units · Derivative | 80,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028156 · doc4.xml · derivative · entry 3 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,128 Underlying: Class A Common Stock · 80,128 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. F3 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Read SEC document |
| May 08, 2022 Filed May 10, 2022 22:44 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionRestricted Stock Units · Derivative | 35,406 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028156 · doc4.xml · derivative · entry 2 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 35,406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: On May 5, 2021 the reporting person was granted 35,406 restricted stock units vesting on May 8, 2022. F2 · derivative.expiration_date: On May 5, 2021 the reporting person was granted 35,406 restricted stock units vesting on May 8, 2022. Read SEC document |
| May 08, 2022 Filed May 10, 2022 22:44 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionClass A Common Stock | 35,406 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-028156 · doc4.xml · nonDerivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 21:19 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionRestricted Stock Unit · Derivative | 508 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001761 · primarydocument.xml · derivative · entry 2 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,015 Underlying: Common Stock, par value $0.001 · 1,523 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F2 · derivative.exercise_date: The RSUs become vested in substantially equal annual installments over the 3 years following February 22, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs become vested in substantially equal annual installments over the 3 years following February 22, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 21:19 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionCommon Stock, par value $0.001 | 508 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-001761 · primarydocument.xml · nonDerivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 508 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 12:10 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantRestricted Stock Unit · Derivative | 1,379 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-083134 · tm2120211-8_4seq1.xml · derivative · entry 2 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,379 Underlying: Common Stock, par value $0.001 · 1,379 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F3 · derivative.exercise_date: The RSUs become fully vested on June 17, 2022 or the 2022 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F3 · derivative.expiration_date: The RSUs become fully vested on June 17, 2022 or the 2022 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 12:10 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantStock Option (option to buy) · Derivative | 2,455 | $0.00 Strike: $41.70 | $0.00 |
DisclosureSEC source: 0001104659-21-083134 · tm2120211-8_4seq1.xml · derivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,455 Underlying: Common Stock, par value $0.001 · 2,455 shares Expires 2031-06-17 F1 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 17, 2021, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| May 06, 2021 Filed May 7, 2021 18:06 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionRestricted Stock Units · Derivative | 46,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-030807 · doc4.xml · derivative · entry 3 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 46,218 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: On May 5, 2020 the reporting person was granted 46,218 restricted stock units vesting on May 6, 2021. F3 · derivative.expiration_date: On May 5, 2020 the reporting person was granted 46,218 restricted stock units vesting on May 6, 2021. Read SEC document |
| May 06, 2021 Filed May 7, 2021 18:06 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionClass A Common Stock | 46,218 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-030807 · doc4.xml · nonDerivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 05, 2021 Filed May 7, 2021 18:06 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | GrantRestricted Stock Units · Derivative | 35,406 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-030807 · doc4.xml · derivative · entry 2 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,406 Underlying: Class A Common Stock · 35,406 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. F2 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:01 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantRestricted Stock Unit · Derivative | 1,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-031661 · tm218484-4_4seq1.xml · derivative · entry 2 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,523 Underlying: Common Stock, par value $0.001 · 1,523 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F3 · derivative.exercise_date: The RSUs become vested in substantially equal annual installments over the 3 years following February 22, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F3 · derivative.expiration_date: The RSUs become vested in substantially equal annual installments over the 3 years following February 22, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:01 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantStock Option (option to buy) · Derivative | 2,562 | $0.00 Strike: $57.47 | $0.00 |
DisclosureSEC source: 0001104659-21-031661 · tm218484-4_4seq1.xml · derivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,562 Underlying: Common Stock, par value $0.001 · 2,562 shares Expires 2031-03-01 F1 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following February 22, 2021, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 21:07 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionRestricted Stock Units · Derivative | 7,522 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-064378 · doc4.xml · derivative · entry 2 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 7,522 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock units represents a contingent right to receive on share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: On December 14, 2019, the reporting person was granted 7,522 restricted stock units vesting on December 15, 2020. F2 · derivative.expiration_date: On December 14, 2019, the reporting person was granted 7,522 restricted stock units vesting on December 15, 2020. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 21:07 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionClass A Common Stock | 7,522 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-064378 · doc4.xml · nonDerivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock units represents a contingent right to receive on share of the Issuer's Class A Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.